Sanofi's vaccines business is the Global Business Unit of Sanofi responsible for infectious disease vaccines.
Our driving goal is to protect people from infectious diseases, by creating safe and effective vaccines. We are not only at the forefront of conquering newly targeted infectious diseases, but also leading the way in expanding immunization across all age groups, including adolescents and the elderly. Our company offers the broadest range of vaccines in the world, providing protection against 17 bacterial and viral diseases. We distribute more than 1 billion doses of vaccine each year, making it possible to vaccinate more than 500 million people across the globe.
We welcome the opportunity to evaluate technologies related to the development and production of human vaccines, both prophylactic and therapeutic, including vaccines for infectious and chronic diseases.
Sanofi’s vaccines business has a strong commitment to Research and Development partnerships with major universities, research institutes, government and non-government organization, and biotechnology companies. The company's collaborations cover virtually all aspects of vaccine development, including early-stage research.
Examples of current partnerships and technology investments include: mRNA as a vaccine platform and mRNA delivery systems; an antibody to protect all infants from RSV; vaccines for COVID-19, Respiratory Syncytial virus, Dengue fever, S. pneumoniae; pediatric combination vaccines; large-scale, cell culture-based virus production; immunomodulators and; adjuvant formulations conjugate vaccine production; and vaccine delivery systems;
A company partnering with Sanofi’s vaccines business interacts with a multidisciplinary team that has years of experience in working to ensure that partnerships are executed successfully and nurtured for the mutual benefit of all parties.
This approach utilizes the value-added Sanofi’s vaccines business alliance management capability, which focuses on the relationship by facilitating open communication, trust, understanding and clear expectations across the project lifespan. Combined with the technical competency of the alliance, this balance provides a well-rounded environment for your technology to flourish.